AnanthNatarajanMD

Summary

• Dr. Natarajan is a physician and engineer who specializes in utilization of advanced technology to solve pressing clinical problems. He founded Infinite Biomedical Technologies (IBT) in 1997 and served as the Chief Executive Officer of the company for over ten years.
      
  IBT has been involved in launching several related companies, including a healthcare information technology company. Vigilant Medical provides medical image sharing for clients, which have included four of the “Top 10 Heart Hospitals” as ranked by U.S. News and World Report. Over 40,000 patients per year are cared for using the Vigilant system.
  
  Currently IBT is developing dexterous prosthetic technology for upper limb amputees, including a machine learning control system, flexible batteries, and advanced electrodes. Over 3,000 amputees in thirty-one countries are currently using one or more components of this system. Ananth has also been an active angel investor and helped fund over a dozen early-stage technology companies, including Vaxart (NASDAQ: VXRT).
  
  Ananth received the TR35 award from Massachusetts Institute of Technology’s Technology Review and the Duke University Engineering Distinguished Young Alumnus Award. He has been featured in the Red Herring magazine in a cover story as one of “5 Technology Innovators Changing the World.” He is a member of the California Club, the Athenaeum, and the Economic Round Table (Past-President).
  
  He currently serves as the Chairman of the Board for Infinite Biomedical Technologies, BlueCode AI, Point Designs, Team Med Ventures and Vigilant Medical, and as a member of the Duke University Biomedical Engineering Advisory Board. In the past he has served on the Boards of the Caltech Associates (Past President), HIVE Lighting, Innovate Pasadena, the Pasadena Angels, and the Pasadena Symphony. He is also Past President of the Physicians’ Wine & Food Society. Currently, he is Chairman of the NIH Neurological Sciences and Disorders C panel (NSD-C).